CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 13D and 13G filings for Pluristem Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-06-01 07:36 am Sale |
2021-05-28 | 13G | Pluristem Therapeutics Inc. PSTI |
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | 3,121,918 9.800% |
-955,671 (-23.44%) |
Filing |
| 2021-02-05 08:30 am Purchase |
2020-12-31 | 13G | Pluristem Therapeutics Inc. PSTI |
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | 4,077,589 15.900% |
229,006 (+5.95%) |
Filing |
| 2020-10-05 4:13 pm Purchase |
2020-09-29 | 13G | Pluristem Therapeutics Inc. PSTI |
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | 3,848,583 15.100% |
1,337,272 (+53.25%) |
Filing |
| 2020-06-29 7:22 pm Purchase |
2020-05-27 | 13G | Pluristem Therapeutics Inc. PSTI |
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | 2,511,311 10.080% |
1,419,254 (+129.96%) |
Filing |